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ABSTRACT
Objective: The objective of the current work was to develop Pioglitazone hydrochloride (HCl) pellets coated with natural polymer extracted from peas 
gum and also to compare the drug release profile with coatings containing semi-synthetic and synthetic polymers.
Methods: Fluidized bed coating technique was used to develop pellets. A 22 factorial design was employed to study the effect of independent variables 
(inlet air temperature and spray rate), on dependent variables (percentage entrapment efficiency, percentage friability, and average particle size). 
Optimization was done by fitting experimental data to the software program. Obtained pellets were subjected to different evaluation parameters 
which are critical in the development of the dosage form. An in vitro lag phase study was carried out for all batches in simulated gastric fluid (0.1N HCl) 
for 5 h and in vitro drug release study was carried out for optimized batch (E-2 and P-3) in simulated intestinal fluid (pH 7.4 phosphate buffer).
Results: The optimized batches E-2 and P-3 showed satisfactory percentage entrapment efficiency of 92.66±1.52, percentage friability of 0.57±0.03, 
and average particle size of 1424±16 μm. All batches maintained lag phase for 5 h in 0.1N HCl. An optimized batch of two different sizes exhibited a 
burst release within 30 min in a simulated intestinal fluid with no significant difference in release rate constant (*p>0.05) and followed first-order 
kinetics.
Conclusion: Thus, Pioglitazone HCl pulsatile pellets were successfully developed for treating diabetes mellitus by fluidized bed coating technique 
employing factorial design.
Keywords: Pioglitazone hydrochloride, Peas gum, Eudragit L100, Pellets, Fluidized bed coating, Optimization, Central composite design.
INTRODUCTION
Diabetes mellitus, or simply diabetes, is a group of diseases characterized 
by high blood glucose levels that result from defects in the body’s ability 
to produce and/or use insulin. It is a condition primarily defined by the 
level of hyperglycemia giving rise to a risk of microvascular damage 
(retinopathy, nephropathy, and neuropathy). It is associated with 
reduced life expectancy, significant morbidity due to specific diabetes-
related microvascular complications, increased risk of macrovascular 
complications (ischemic heart disease, stroke, and peripheral vascular 
disease), and diminished quality of life [1].
Several pathogenetic processes are involved in the development of 
diabetes. These include processes, which destroy the beta cells of the 
pancreas with consequent insulin deficiency, and others that result 
in resistance to insulin action. The abnormalities of carbohydrate, fat, 
and protein metabolism are due to deficient action of insulin on target 
tissues resulting from insensitivity or lack of insulin.
Diabetes mellitus is characteristic with symptoms such as thirst, 
polyuria, blurring of vision, and weight loss. Often symptoms are 
not severe or may be absent [2]. Diagnosis of diabetes mellitus is 
easily established when a patient presents the classic symptoms of 
hyperglycemia and has a random blood glucose value of 200 mg/dL or 
higher and confirmed on another occasion. Basic diagnosis of diabetes 
includes fasting plasma glucose (FPG) test measures blood glucose in a 
person who has not eaten anything for at least 8 h. This test is used to 
detect diabetes and prediabetes. An oral glucose tolerance test (OGTT) 
measures blood glucose after a person fasts at least 8 h and 2 h after the 
person drinks a glucose-containing beverage [3].
FPG test is most reliable when done in the morning. Research has 
shown that the OGTT is more sensitive than the FPG test for diagnosing 
prediabetes, but it is less convenient to administer. A random plasma 
glucose test, also called a casual plasma glucose test, measures blood 
glucose without regard to when the person being tested last ate. 
This test along with an assessment of symptoms is used to diagnose 
diabetes but not prediabetes. Test results indicating that a person has 
diabetes should be confirmed with a second test on a different day 
(Twillman, 2002).
The treatment of acute diseases or chronic illness has been achieved 
by delivery of drugs to patients for many years. Tablets and capsules 
are generally formulated to release the drug immediately after oral 
administration to hasten systemic absorption. These are called 
immediate- release products. Other products like modified-release 
dosage forms have been developed to release the drug at a controlled 
rate. The purpose is generally either to avoid contact with gastric 
fluids (acidic environment) or to prolong drug input in the systemic 
circulation [4]. These drug delivery systems include tablets, parenteral, 
suspensions, creams, ointments, liquids, and aerosols.
Pellets are one such type of modified drug delivery system they are 
agglomerates of fine powders or granules of bulk drugs and excipients. 
They consist of small, free-flowing, spherical or semi-spherical solid 
units and are intended usually for oral administration. Pellets are of 
great interest to the pharmaceutical industry for a variety of reasons. 
Pelletized products not only offer flexibility in dosage form design and 
development but are also utilized to improve the safety and efficacy of 
bioactive agents. However, the single most important factor responsible 
for the proliferation of pelletized products is the popularity of controlled 
© 2019 The Authors. Published by Innovare Academic Sciences Pvt Ltd. This is an open access article under the CC BY license (http://creativecommons. 
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release technology in the delivery of drugs. Pellets containing active 
ingredient are administered in the form of suspensions, capsules, or 
disintegrating tablets [5-7] (Fig 1).
Pioglitazone HCl was the drug chosen to be formulated as extended 
release pellets as it selectively stimulates nuclear peroxisome 
proliferators, modulates the transcription of insulin-sensitive genes 
involved in the control of glucose in the lipid metabolism. This drug 
also decreases the level of triglycerides and increases the high-density 
lipoproteins without changing low-density lipoproteins and the total 
cholesterol in the patients with disorders of lipid metabolism. It has a 
plasma half-life of 3–7 h.
MATERIALS
Chemicals
Pioglitazone HCl was obtained as a gift sample from Dr. Reddy’s, 
Povidone, HPMC, Eudragit L-100 from Evonik Mumbai, Pisum sativum 
gum, acetone, methanol, isopropyl alcohol, and polyvinylpyrrolidone 
(PVP) K30.
Equipment
Ultraviolet-visible spectrophotometer, SL-164 double beam 
spectrophotometer, dissolution test apparatus, differential scanning 
calorimeter (DSC), Fourier transmitter-infrared spectroscopy (FT-IR), 
and fluidized bed processor (FBP) are used.
METHODOLOGY
Isolation of gum from P. sativum (peas)
About 250 g of P. sativum seeds are weighed and pulverized to a fine 
powder a mixer grinder. Powder of P. sativum was soaked in 1000 ml 
of water for 24 h after boiled for 2 h.The extract was filtered, and gum 
mucilage was isolated by separation from the marc. Ethyl alcohol was 
added to precipitate the gum and the gum was separated by filtration. 
Isolation was continued until the material was free of gum, separated 
gum was dried in hot air oven at temperature 40°C, and dried gum 
was powdered and stored in airtight containers at room temperature 
(Figs. 2 and 3).
Preformulation studies for pioglitazone HCl
This study is helpful for the investigation of physical and chemical 
properties of a drug substance alone and when compared with 
excipients. It is the first step of the rationale for the development of 
dosage form. Parameters such as organoleptic properties, solubility, 
bulk density, moisture content, angle of repose, tapped density, 
differential scanning calorimetry, and FT-IR analysis to check the drug-
excipient compatibility in 1:1 ratio (Fig. 4 and Table 1).
Formulation of extended-release pellets
In the manufacturing of extended-release Pioglitazone HCl pellets, there 
are three stages involved in this process they include drug loading, 
barrier coating, and functional coating. The development of the present 
study was mainly based on the process of binding of the drug to inert 
sphere and binding of polymer on to drug-coated inert spheres. For 
Fig. 1: Different formal spatial structures of liquid-bound 
agglomerates depending on liquid saturation
Fig. 2: Powder of Pisum sativum seeds
Fig. 3: Mucilage of Pisum sativum gum
Fig. 4: Preliminary photochemical tests
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drug loading, primary coating solution was prepared using PVP K30, 
methanol, along with the drug on to the inert spheres. Pioglitazone HCl 
was weighed accurately and dissolved in 50 ml of solvent (methanol) 
by slow addition, and continuous stirring PVP K30 was weighed and 
Table 1: Preliminary Phytochemical test for P. sativum seed gum [8,9]
S. No Name of test Procedure
1 Molisch test (carbohydrates) To the gum add 1 ml of freshly prepared α-naphthol solution and add conc. H2SO4 from the sides of 
the test tube under tap water. Violet ring may be formed at the junction of two liquids
2 Legal’s test (glycosides) Take extract and dissolved in pyridine and made alkaline with sodium nitroprusside solution. The 
solution may become pink or red
3 Dragendroff’s test (Alkaloids) To the gum add Dragendroff’s reagent (potassium bismuth iodide solution) to the extract. Orange-red 
precipitate may be formed
4 Salkowski test (Steroids) To the gum extract and dissolved in few ml of chloroform and filtered. To the filtrate add an equal 
volume of conc. H2SO4. Blue or red color may be formed
5 Alkaline reagent test (Flavonoids) To the gum add few drops of sodium hydroxidesolution.
Intensive yellow color may be observed and became colorless on addition of dilute acid
6 Ninhydrin test (Amino acids) To the small quantity of gum add 2 drops of freshly prepared 0.2% Ninhydrin reagent (0.1% solution 
in n-butanol). Heat for few minutes, blue color may be formed
7 Ruthenium test (Gums) Take the small quantity of dried mucilage powder and mount it on the slide with ruthenium red 
solution and observe it under a microscope. Pink color develops
8 Mucilage test (Gums) Take 10 ml of aqueous extract of gum and add slowly to 25 ml of absolute alcohol with constant 
stirring. Filtered the precipitate and dried in air and examined for its swelling properties may indicate 
the presence of mucilage
P. sativum: Pisum sativum
Fig. 5: Fourier transmitter-infrared spectroscopy spectrum of pure pioglitazone HCl
Fig. 6: Fourier transmitter-infrared spectroscopy spectrum of pioglitazone HCl + Eudragit-L 10
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dissolved in the above solution with continuous stirring made up to 
50 ml with solvent. 50 g of inert spheres are weighed and kept aside 
pan was preheated, and the temperature of the inlet was maintained 
at 50–55°C. Inert spheres were charged into the pan and operated 
according to the set parameters. The second step is barrier coating 
in this barrier coating solution was prepared using HPMC E50 LV in 
heated purified water. Purified water was taken and kept for heating 
until it reached 60°C–70°C.
The required quantity of HPMC E50 LV was taken and dissolved in 
purified water with continuous stirring for 30 min (or) until a clear 
solution was formed. The resulting solution was cooled to room 
temperature and filtered through nylon mesh, labeled and used for 
coating purpose. Drug-loaded pellets were loaded into FBP, and the 
pellets were warmed until the product temperature of 40±2°C was 
obtained. The sub coating dispersion prepared was sprayed with the 
following parameters. The dispersion was kept under continuous 
stirring during the coating process. The coating was continued until 
target weight build up was obtained. The fluidization air flow was 
reduced to a suitable level, and the sub-coated pellets were dried at 
Fig. 7: Fourier transmitter-infrared spectroscopy spectra of a physical mixture of pioglitazone HCl and peas gum
Fig. 8: Calibration curve of Pioglitazone HCl
Fig. 9: Scanning electron microscopy of uncoated inert spheres
Fig. 10: Scanning electron microscopy of Pioglitazone HCl 
prepared by fluidized bed coating
Table 2: Phytochemical test of P. sativum gum




1 Test for carbohydrates Molisch test +
2 Test for alkaloids Dragendroff’s test −
3 Test for steroids and 
sterols
Salkowski test −
4 Test for glycosides Legal’s test −
5 Test for flavonoids Alkaline reagent test −
6 Test for proteins and 
amino acids
Ninhydrin test +
7 Test for gums Mucilage test +
P. sativum: Pisum sativum
442
Asian J Pharm Clin Res, Vol 12, Issue 3, 2019, 438-446
 Gowthami et al. 
the product temperature of 33°C–35°C for 15–20 min. The final step 
includes functional coating here using natural P. sativum gum and 
synthetic Eudragit L-100 separately coating solutions are prepared, and 
the coating was done, and the drug release profile are compared.
Estimation of drug content
Accurately weigh 100 g of formulation place it in 100 ml volumetric 
flask to this add little quantity of methanol dropwise and wait for 
10 min for complete so that pellets will be dissolved finally make up 
the volume with methanol. Filter the solution from the 1 ml of the 
filtrate was diluted to 10 ml with methanol. The resulted solution was 
analysed in UV-Spectrophotometer at 225nm after suitable dilution. 
Content uniformity test was evaluated for the formulation by collecting 
samples from three different portions of the bulk, and the results were 
expressed, and results were reported.
In vitro - dissolution studies
The study was carried out in 900 ml of 0.1N HCl, PH 6.8 phosphate 
buffer at 50 rpm. Capsules containing accurately weighed quantity 
of drug loaded pellets equivalent to 15mg to 45mg of Piolglitazone 
HCl were taken in USP dissolution apparatus type-I to study  drug 
release from various formulations. The dissolution medium was kept 
Table 3: Formulation of extended release pellets of pioglitazone HCL using Eudragit L-100 (EL100) as a synthetic polymer
S. No Primary coating Sub coating Functional coating
Ingredient Quantity Ingredient Quantity Ingredients E-1 E-2 E-3 E-4 
1 Drug 1.5 g Primary coated pellets (g) 52 g Sub-coated pellets (g) 53 g 53 g 53 g 53 g
2 PVP K30 0.5% HPMC E50LV 1% Eudragit L-100 1% 2% 3% 4%
3 Methanol 50 ml Purified water q.s Alcohol 50 ml 100 ml 150 ml 200 ml
4 Inert spheres 50 g
Total quantity 52 g 53 g 54 g 55 g 56 g 58 g
PVP: Polyvinylpyrrolidone
Table 4: Formulation of extended release pellets of pioglitazone HCl using P. sativum seed gum as natural polymer
S. No Primary coating Sub coating Functional coating
Ingredients Quantity Ingredients Quantity Ingredients P-1 P-2 P-3 P-4
1 Drug 1.5 g Primary coated pellets (g) 52 Sub-coated pellets 53 53 53 53
2 PVP K30 0.5% HPMC E50LV 1% P. sativum seed gum 1% 2% 5% 4%
3 Methanol (ml) 50 ml Purified water q.s Purified water 50 100 250 200
4 Inert spheres 50 g - - - - - - -
Total Quantity 52 g 53 g 54 g 55 g 58 g 57 g
PVP: Polyvinylpyrrolidone
Table 5: Micromeritic characterization of Pioglitazone HCl pellets
S. No Formulations Bulk density±SD (gm/ml) Tapped density±SD (gm/ml) Hausners ratio±SD Angle of Repose Ѳ± SD°
1 E-1 0.674 0.706 1.047 16.6
2 E-2 0.676 0.715 1.054 21.8
3 E-3 0.654 0.695 1.069 16.34
4 E-4 0.653 0.694 1.068 16.33
5 P-1 0.682 0.708 1.041 21.8
6 P-2 0.678 0.717 1.049 16.74
7 P-3 0.634 0.675 1.049 16.12
8 P-4 0.634 0.675 1.049 16.12
Fig. 11: Differential scanning calorimeter curve of pioglitazone HCl
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Fig. 12: Differential scanning calorimeter curve of Eudragit L-100
Fig. 13: Differential scanning calorimeter curve of pioglitazone HCl + Eudragit L-100
Fig. 14: Differential scanning calorimeter curve of peas gum + Pioglitazone HCl
444
Asian J Pharm Clin Res, Vol 12, Issue 3, 2019, 438-446
 Gowthami et al. 
in a thermostatically controlled water bath, maintained at 37±0.5°C. 
The stirrer hood was lowered so that the lower end of the basket was 
25 mm above the base of the beaker. At different time interval, 5 ml 
of the sample was withdrawn and analyzed spectrophotometrically 
at 225 nm for drug release. At each time of interval, 5 ml of fresh 
dissolution medium was replaced into dissolution flask.
Mathematical modeling and comparison of dissolution profiles
Release kinetics of all the formulations was studied using Zero-order, 
First-order, Higuchi, and Korsmeyer-Peppas mathematical models the 
model which best fits dissolution profile of various formulations was 
chosen [10-12].
RESULTS AND DISCUSSION
Physiochemical properties of P. sativum gum
Freshly prepared P. sativum gum is green in color with a pungent odor, 
Fig. 15: Comparison of in vitro dissolution profile of formulation 
E -1 to E-4
Fig. 16: Comparison of in vitro dissolution profile of formulation 
P -1 to P-4
Fig. 17: First-order plot of dissolution profile of E- 1 to E-4
Table 6: Percentage drug content





Fig. 18: First-order plot of dissolution profile of P-1 to P-4
Fig. 19: Higuchi plot of dissolution profile of E-1 to E-4
Fig. 20: Higuchi plot of dissolution profile of P-1 to P-4
Fig. 21: Korsmeyer-Peppas plot of dissolution profiles of E-1 to 
E-4
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found to soluble in water and insoluble in organic solvents such as 
ethanol, alcohol, and acetone, and pH of 2% w/v aqueous mucilage 
was 7.22–7.30. The initially apparent viscosity of 2% w/v of peas 
seed gum was less and almost constant after 1 h of soaking time and 
further increase the viscosity after 3 h. The apparent viscosity of 2% 
w/v of gum dispersion using spindle II (DV-II+ pro viscometer) and 
the viscosity is measured at different rpm, i.e., from 10 to 100. Gum 
dispersion followed non-Newtonian flow because it has different 
viscosity at a different shear rate (Table 2).
Physicochemical characterization of drug
Physicochemical parameters of the obtained sample of the drug were 
analyzed color was white with a bitter taste in amorphous state soluble 
in methanol with a melting point 194°C.
FR-IR studies for the pure drug, drug along with eudragit L-100 
and seed gum
Pioglitazone HCl and peas gum show no uncountable peak which 
confirms the absence of chemical interaction between the drug and 
polymer. The IR spectra of the drug and polymer, drug-polymer mixture 
are shown in Figs. 5-7 and Tables 3 and 4. On comparison of a physical 
mixture of Pioglitazone HCl and Eudragit L-100, Pioglitazone HCl and 
P. sativum gum by superimposing IR spectra there is no interaction 
between drug and polymer.
Calibration curve of pioglitazone HCl
A calibration curve was constructed for Pioglitazone HCl in methanol at 
225 nm using ultraviolet-visible spectrophotometer (Fig. 8).
Evaluation of the micromeritic properties of pioglitazone HCl 
pellets
The flow properties of pellets were evaluated for bulk density, tapped 
density angle of repose, Carr’s index, and Haussner’s ratio. The limits 
were given in Table 5.
Drug content
The content uniformity test was evaluated for the formulation by 
collecting samples from three different portions of the bulk, and the 
results were expressed. (Table 6) The results were reported as:
Characterization of pellets
Based on the dissolution studies performed on all the batches of 
pellets, some of the optimized formulations were selected and further 
investigated for DSC and scanning electron microscopy (SEM) studies.
Shape and surface roughness
The pellets formulation was examined by SEM for the surface 
characteristic, SEM photographs of pellets were shown in Figs. 9 
and 10. The pellets prepared by fluid bed coating have smooth surface 
with minimal pores indicated the uniform coating of pellets.
DSC studies
About 3.052 mg of sample was weighed in a standard open aluminum 
pan, and scanned from 30 to 300°C, at a heating rate of 10°C min while 
being purged with dry nitrogen (Figs. 11-22 and Tables 7 and 8). Results 
are given as thermographs.
CONCLUSION
In the present investigation, Pioglitazone HCl was taken as a model 
drug in the sustained drug delivery system for extending drug release 
for a prolonged period of time as pellets. Multiparticulate drug 
delivery system is developed by employing FBP, as multiparticulates 
are more advantageous over single unit systems due to their small 
size. Extended-release pellets of Pioglitazone HCL were formulated 
and evaluated, Eudragit L-100 is used as a synthetic polymer to retard 
the release of the drug, and P. sativum seed gum is used as a natural 
polymer in the development of extended-release formulations. The best 
formulations were selected based on in vitro dissolution studies. Based 
on preformulation studies, it was proved that there are no compatibility 
issues regarding the excipients with the drug. SEM analysis was 
performed for the pellets prepared by fluid bed coating. The pellets 
prepared by FBP were having a smooth surface with minimal pores 
which indicate uniform coating of pellets. Drug content and content 
Table 7: Drug release profile of Pioglitazone HCl pellets prepared by FBP
S. No Dissolution medium Time (h) Cumulative % drug release (%)
E-1 E-2 E-3 E-4 P-1 P-2 P-3 P-4
1 0. 1N HCl 0 0 0 0 0 0 0 0 0
2 1 0.49 0.68 0.27 0.99 0.57 0.41 0.71 0.87
3 2 0.78 0.49 0.73 0.11 0.86 0.45 0.71 0.21
4 PH 6.8 Phosphate buffer 4 68.71 37.34 21.24 12.83 75.9 78.9 38.1 15.78
5 6 75.27 46.54 31.89 15.13 83.97 81 43.7 23.98
6 8 83.34 63.67 48.89 19.76 91.58 89.13 61.8 39.89
7 10 - 88.76 54.85 21.85 92.14 92.9 79.81 42.89
8 12 - 96.13 79.18 30.86 - - 96.57 54.7
Marketed Pioglitazone tablets shown a release profile up to 3–6 h, FBP: Fluidized bed processor
Table 8: Dissolution kinetics of Pioglitazone HCL pellets 
formulated with natural and synthetic polymers
Formulation code Correlation coefficient (R2)
Zero-order First-order Higuchi Peppas
E-1 0.864 0.873 0.832 0.875
E-2 0.973 0.866 0.946 0.864
E-3 0.968 0.538 0.924 0.931
E-4 0.957 0.689 0.703 0.658
PS-1 0.862 0.906 0.825 0.568
PS-2 0.844 0.908 0.820 0.836
PS-3 0.960 0.763 0.949 0.140
PS-4 0.969 0.925 0.943 0.788
Fig. 22: Korsmeyer-Peppas plot of dissolution profile of P-1 to P-4
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uniformity were found to be good and gave reproducible results. It was 
found that among the various batches of the formulations E-2 and P-3 
prepared by fluid bed coating were found to release the drug over an 
extended period of time, i.e., up to 12 h. Release kinetics revealed that 
all the formulations were following zero-order drug release and are 
suitable for prolonging the antidiabetic activity. The current antidiabetic 
medications available in the market containing Pioglitazone HCl do not 
possess sustained release formulations. Furthermore, the use of natural 
polymers must be adopted to reduce toxic solvents utility in fluidized 
bed coating systems and fasten the bioavailability of the medicament. 
Hence, the present investigation could be apt enough to meet the 
requirements of polymer availability on a large scale.
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